|
1
|
Nasseri Y and Langenfeld SJ: Imaging for
colorectal cancer. Surg Clin North Am. 97:503–513. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mármol I, Sánchez-de-Diego C, Pradilla
Dieste A, Cerrada E and Rodriguez Yoldi MJ: Colorectal carcinoma: A
general overview and future perspectives in colorectal cancer. Int
J Mol Sci. 18:1972017. View Article : Google Scholar
|
|
3
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Patel SG and Ahnen DJ: Colorectal cancer
in the young. Curr Gastroenterol Rep. 20:152018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Passiglia F, Bronte G, Bazan V, Galvano A,
Vincenzi B and Russo A: Can KRAS and BRAF mutations limit the
benefit of liver resection in metastatic colorectal cancer
patients? A systematic review and meta-analysis. Crit Rev Oncol
Hematol. 99:150–157. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Walther A, Johnstone E, Swanton C, Midgley
R, Tomlinson I and Kerr D: Genetic prognostic and predictive
markers in colorectal cancer. Nat Rev Cancer. 9:489–499. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kaelin WG Jr: The concept of synthetic
lethality in the context of anticancer therapy. Nat Rev Cancer.
5:689–698. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mattick JS and Rinn JL: Discovery and
annotation of long noncoding RNAs. Nat Struct Mol Biol. 22:5–7.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Talyan S, Andrade-Navarro MA and Muro EM:
Identification of transcribed protein coding sequence remnants
within lincRNAs. Nucleic Acids Res. 46:8720–8729. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang L, Cho KB, Li Y, Tao G, Xie Z and Guo
B: Long noncoding RNA (lncRNA)-mediated competing endogenous rna
networks provide novel potential biomarkers and therapeutic targets
for colorectal cancer. Int J Mol Sci. 20:57582019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qi X, Zhang DH, Wu N, Xiao JH, Wang X and
Ma W: ceRNA in cancer: Possible functions and clinical
implications. J Med Genet. 52:710–718. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang Y, Hou J, He D, Sun M, Zhang P, Yu Y
and Chen Y: The emerging function and mechanism of ceRNAs in
cancer. Trends Genet. 32:211–224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Song YX, Sun JX, Zhao JH, Yang YC, Shi JX,
Wu ZH, Chen XW, Gao P, Miao ZF and Wang ZN: Non-coding RNAs
participate in the regulatory network of CLDN4 via ceRNA mediated
miRNA evasion. Nat Commun. 8:2892017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong CC, Qian Y, Li X, Xu J, Kang W, Tong
JH, To KF, Jin Y, Li W, Chen H, et al: SLC25A22 promotes
proliferation and survival of colorectal cancer cells With KRAS
mutations and xenograft tumor progression in mice via intracellular
synthesis of aspartate. Gastroenterology. 151:945–960.e6. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Song Y, Chen QT and He QQ: Identification
of key transcription factors in endometrial cancer by systems
bioinformatics analysis. J Cell Biochem. 120:15443–15454. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reshef DN, Reshef YA, Finucane HK,
Grossman SR, McVean G, Turnbaugh PJ, Lander ES, Mitzenmacher M and
Sabeti PC: Detecting novel associations in large data sets.
Science. 334:1518–1524. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tripathi S, Pohl MO, Zhou Y,
Rodriguez-Frandsen A, Wang G, Stein DA, Moulton HM, DeJesus P, Che
J, Mulder LC, et al: Meta- and orthogonal integration of influenza
‘OMICs’ data defines a role for UBR4 in virus budding. Cell Host
Microbe. 18:723–735. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng Y, Fang YC and Li J: PD-L1
expression levels on tumor cells affect their immunosuppressive
activity. Oncol Lett. 18:5399–5407. 2019.PubMed/NCBI
|
|
23
|
Tai P, Yu E, Cserni G, Vlastos G, Royce M,
Kunkler I and Vinh-Hung V: Minimum follow-up time required for the
estimation of statistical cure of cancer patients: Verification
using data from 42 cancer sites in the SEER database. BMC Cancer.
5:482005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Afrăsânie VA, Marinca MV, Alexa-Stratulat
T, Gafton B, Păduraru M, Adavidoaiei AM, Miron L and Rusu C: KRAS,
NRAS, BRAF, HER2 and microsatellite instability in metastatic
colorectal cancer-practical implications for the clinician. Radiol
Oncol. 53:265–274. 2019. View Article : Google Scholar
|
|
25
|
Cicenas J, Tamosaitis L, Kvederaviciute K,
Tarvydas R, Staniute G, Kalyan K, Meskinyte-Kausiliene E,
Stankevicius V and Valius M: KRAS, NRAS and BRAF mutations in
colorectal cancer and melanoma. Med Oncol. 34:262017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Porru M, Pompili L, Caruso C, Biroccio A
and Leonetti C: Targeting KRAS in metastatic colorectal cancer:
Current strategies and emerging opportunities. J Exp Clin Cancer
Res. 37:572018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li DS, Ainiwaer JL, Sheyhiding I, Zhang Z
and Zhang LW: Identification of key long non-coding RNAs as
competing endogenous RNAs for miRNA-mRNA in lung adenocarcinoma.
Eur Rev Med Pharmacol Sci. 20:2285–2295. 2016.PubMed/NCBI
|
|
28
|
Liu J, Kruswick A, Dang H, Tran AD, Kwon
SM, Wang XW and Oberdoerffer P: Ubiquitin-specific protease 21
stabilizes BRCA2 to control DNA repair and tumor growth. Nat
Commun. 8:1372017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cui K, Liu C, Li X, Zhang Q and Li Y:
Comprehensive characterization of the rRNA metabolism-related genes
in human cancer. Oncogene. 39:786–800. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li X, Li B, Ran P and Wang L:
Identification of ceRNA network based on a RNA-seq shows prognostic
lncRNA biomarkers in human lung adenocarcinoma. Oncol Lett.
16:5697–5708. 2018.PubMed/NCBI
|
|
31
|
Xu XT, Xu Q, Tong JL, Zhu MM, Nie F, Chen
X, Xiao SD and Ran ZH: MicroRNA expression profiling identifies
miR-328 regulates cancer stem cell-like SP cells in colorectal
cancer. Br J Cancer. 106:1320–1330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin
P, Lu Y, Li Q and Liu J: MiR-139 inhibits invasion and metastasis
of colorectal cancer by targeting the type I insulin-like growth
factor receptor. Biochem Pharmacol. 84:320–330. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo H, Hu X, Ge S, Qian G and Zhang J:
Regulation of RAP1B by miR-139 suppresses human colorectal
carcinoma cell proliferation. Int J Biochem Cell Biol.
44:1465–1472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang F, Ma YL, Zhang P, Shen TY, Shi CZ,
Yang YZ, Moyer MP, Zhang HZ, Chen HQ, Liang Y and Qin HL: SP1
mediates the link between methylation of the tumour suppressor
miR-149 and outcome in colorectal cancer. J Pathol. 229:12–24.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu C, Kelnar K, Vlassov AV, Brown D, Wang
J and Tang DG: Distinct microRNA expression profiles in prostate
cancer stem/progenitor cells and tumor-suppressive functions of
let-7. Cancer Res. 72:3393–3404. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lulla AR, Slifker MJ, Zhou Y, Lev A,
Einarson MB, Dicker DT and El-Deiry WS: miR-6883 family miRNAs
target CDK4/6 to induce G1 phase cell-cycle arrest in
colon cancer cells. Cancer Res. 77:6902–6913. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yang R, Wei M, Yang F, Sheng Y and Ji L:
Diosbulbin B induced G2/M cell cycle arrest in
hepatocytes by miRNA-186-3p and miRNA-378a-5p-mediated the
decreased expression of CDK1. Toxicol Appl Pharmacol. 357:1–9.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Spiller F, Medina-Pritchard B, Abad MA,
Wear MA, Molina O, Earnshaw WC and Jeyaprakash AA: Molecular basis
for Cdk1-regulated timing of Mis18 complex assembly and CENP-A
deposition. EMBO Rep. 18:894–905. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lopez-Mejia IC, Lagarrigue S, Giralt A,
Martinez-Carreres L, Zanou N, Denechaud PD, Castillo-Armengol J,
Chavey C, Orpinell M, Delacuisine B, et al: CDK4 phosphorylates
AMPKα2 to inhibit its activity and repress fatty acid oxidation.
Mol Cell. 68:336–349.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
